About our
Database
The IHSI Database stands at the forefront of pharmaceutical intelligence, providing member states with an unparalleled resource for tracking, analyzing, and responding to emerging pharmaceutical developments. With its state-of-the-art AI capabilities, rigorous data validation frameworks, and commitment to transparency, IHSI ensures that its members are equipped with the best available data to navigate the rapidly evolving healthcare landscape.
As pharmaceutical innovations continue to transform global healthcare systems, IHSI remains dedicated to enhancing its database functionalities, expanding its analytical capabilities, and ensuring continuous data refinement. By doing so, the IHSI Database not only provides actionable intelligence for today but also lays the groundwork for more strategic, informed, and data-driven decisions in the future.
Comprehensive Global Pharmaceutical IntelligenceTransparency and Public Data Usage
The IHSI Database serves as a single, consolidated platform for tracking pharmaceutical developments across all therapeutic areas. By meticulously cataloging and structuring pharmaceutical data, IHSI enables stakeholders to conduct thorough analyses and forecast emerging trends within the healthcare sector.
Each record in the database represents an individual pharmaceutical product indication, capturing over 150 unique data fields that encompass regulatory timelines, therapeutic applications, market positioning, and expected pricing trends. The data within the database is curated from publicly available sources such as clinical trial registries, regulatory submissions, and official press releases, ensuring accuracy and credibility.
Moreover, the database is designed to be highly interactive and user-centric, offering functionalities that enhance usability, such as advanced search filters, customizable alerts, and full data export capabilities. This ensures that users can tailor the database’s capabilities to meet their specific needs, facilitating informed decision-making across multiple levels of pharmaceutical governance.
Data Accuracy and Timely Updates
The IHSI Database serves as a single, consolidated platform for tracking pharmaceutical developments across all therapeutic areas. By meticulously cataloging and structuring pharmaceutical data, IHSI enables stakeholders to conduct thorough analyses and forecast emerging trends within the healthcare sector.
Each record in the database represents an individual pharmaceutical product indication, capturing over 150 unique data fields that encompass regulatory timelines, therapeutic applications, market positioning, and expected pricing trends. The data within the database is curated from publicly available sources such as clinical trial registries, regulatory submissions, and official press releases, ensuring accuracy and credibility.
Moreover, the database is designed to be highly interactive and user-centric, offering functionalities that enhance usability, such as advanced search filters, customizable alerts, and full data export capabilities. This ensures that users can tailor the database’s capabilities to meet their specific needs, facilitating informed decision-making across multiple levels of pharmaceutical governance.IHSI does not accept funding or engage in agreements with pharmaceutical companies.
AI-Powered Data Harvesting and Curation
The IHSI Database serves as a single, consolidated platform for tracking pharmaceutical developments across all therapeutic areas. By meticulously cataloging and structuring pharmaceutical data, IHSI enables stakeholders to conduct thorough analyses and forecast emerging trends within the healthcare sector.
Each record in the database represents an individual pharmaceutical product indication, capturing over 150 unique data fields that encompass regulatory timelines, therapeutic applications, market positioning, and expected pricing trends. The data within the database is curated from publicly available sources such as clinical trial registries, regulatory submissions, and official press releases, ensuring accuracy and credibility.
Moreover, the database is designed to be highly interactive and user-centric, offering functionalities that enhance usability, such as advanced search filters, customizable alerts, and full data export capabilities. This ensures that users can tailor the database’s capabilities to meet their specific needs, facilitating informed decision-making across multiple levels of pharmaceutical governance.IHSI employs a hybrid approach combining:
A Trusted Resource for Policy and Pricing Decisions
In an era of increasing pharmaceutical complexity, independent and unbiased data sources are critical for informed policymaking and pricing negotiations. The IHSI Database serves as a trusted public sector resource, ensuring that governments and healthcare organizations have full autonomy over the data they rely on for critical decisions.
One of the core objectives of IHSI is to support HTA bodies, pricing negotiation teams, and policymakers in their evaluations of market access, cost-effectiveness, and therapeutic value of new pharmaceutical products. By providing data on estimated price requests, projected budget impacts, and competitive market analysis, the database helps optimize healthcare spending and enhance value-based decision-making.
Furthermore, IHSI ensures full transparency and independence by exclusively sourcing information from publicly available data. Unlike industry-driven intelligence platforms, which are often subject to confidentiality constraints and proprietary limitations, the IHSI Database operates under an open-access framework, allowing unrestricted use of its data by all member states. This guarantees that policy formulation, pricing negotiations, and market access evaluations are conducted without external influence or bias.
